DealShare in advanced talks to be acquired by Truemeds in share-swap deal
Quick Look
Ecommerce startup DealShare, valued at $1.7 billion at its peak in 2022, is in advanced talks to be acquired by online pharmacy Truemeds in a share-swap transaction that would value it at slightly above its $90 million cash balance, according to sources cited by ET.
AI-generated summary
Why It Matters
DealShare peaked at $1.7B valuation in 2022 but has since seen significant value erosion, now holding approximately $90M in cash.
Ecommerce startup DealShare, which was valued at $1.7 billion at its peak in 2022, is now in advanced talks to be acquired by online pharmacy Truemeds in a share-swap transaction that would value it at a little over its $90 million cash balance, people aware of the matter told ET.Under the proposed structure, Truemeds will issue shares to DealShare’s investors at a valuation of about $600 million, while DealShare is expected to be valued at its
What to Watch
AI outlook — possibilities, not facts
DealShare acquisition by Truemeds will be completed within the next 3 months
Likely · Within months
Open Questions
- What is the exact share swap ratio in the proposed deal?
- Which DealShare investors will receive Truemeds shares?
- Will the acquisition receive regulatory approval?
- What will happen to DealShare's operations post-acquisition?
